Spike Protein Concerns

Bret discusses how the spike protein from COVID vaccines may not remain localized at the injection site, potentially circulating throughout the body and affecting the blood-brain barrier. He connects this phenomenon to symptoms observed in long COVID and post-vaccine syndrome, raising questions about corporate accountability and the implications of liability immunity. The conversation delves into the cytotoxic nature of the spike protein and its unexpected impact on brain health.